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SUMMARY 
Certain anti-H-2 sera contain an antibody-like activity which specifically inhibits 
EAC rosette formation by lymphoid (and not myeloid) cells of certain mouse 
strains. Studies in congenic recombinant mouse strains strongly indicate that at 
least part of the control of susceptibility to inhibition by these antisera is mediated 
by H-2 linked genes, mapping in the I-C subregion or the S region. The strain 
distribution of the trait CRIS indicates that certain H-2 identical mice behave 
differently from one another, pointing toward a component of non-H-2 modu- 
lation of the H-2 linked gene (or to a previously unsuspected H-2 difference). 
Positive sera were usually raised across differences in the D end of the H-2 
complex. The complex implications of this system must be considered in the light 
of known S region involvement in complement metabolism. 
I N T R O D U C T I O N  
The complement receptor (CR) like the Fc receptor, is a well-documented component of the 
cell surface of macrophages and B lymphocytes (Lay & Nussenzweig, 1968; Bianco et al., 
1970). Moreover, like Fc receptors, evidence exists for its presence on subpopulations of T 
lymphocytes and ‘null’ lymphocytes (Amaiz-Villena et al., 1974; Amaiz-Villena & Hay, 
1975). 
However, while Fc receptors are completely inhibited by preincubation of the cells with 
alloantisera (Parish & Hayward, 1974, Dickler & Sachs, 1974; Schirrmacher et al., 1975; 
Halloran et al., 1975) the CR has been reported to resist such inhibition both in rat and in 
mouse (Parish & Hayward, 1974; Dickler & Sachs, 1974). 
We have been studying a mouse CR dependent system in which CR binding is detected by 
rosette formation between mouse cells and antibody- and complement-coated sheep 
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erythrocytes (EAC). Preincubation of the mouse cells with certain mouse H-2 alloantisera 
was found to specifically and consistently inhibit most of these EAC rosettes in some (but 
not all) mouse strains. This suggested that mouse CR inhibition susceptibility (CRIS) by 
H-2 alloantisera might be controlled by one or more previously unsuspected genetic loci. 
We have attempted to answer certain questions about this system: (i) is the inhibitory 
activity in H-2 alloantisera antibody ? (ii) what population of EAC-rosette forming cells is 
inhibited? (iii) is the genetic control of CRIS H-2 linked, and if so, can it be mapped in 
congenic resistant recombinant mouse strains ? (iv) what is the strain distribution of the 
characteristic CRIS? (v) is CRIS genetically controlled by one locus or multiple loci? (vi) 
what are the genetic requirements for the production of the inhibitory activity in an H-2 
alloantiserum ? 
Preliminary results of some of these studies have been presented elsewhere (Arnaiz- 
Villena et al., 1975). The results presented here suggest that CRIS is under complex genetic 
control in part H-2 linked. 
MATERIALS AND METHODS 
Animals 
Two to three month old male and female mice were used. Strains AKR, CBA/H, C3H, 
BlO.BR, DBA/2, BALB/c, C57B1/6, C57B1/10 ('BlO'), BIO.A and A.JAX were bred in the 
London Hospital Medical College from breeding pairs obtained from Laboratory Animal 
Centre, Carshalton, England. Strains BlO.HTT, BlO.A(2R), BlO.A(SR), BlO.A(4R), 
BlO.A(R233), A.TH, A.TL and A.SW were bred in this laboratory from breeding pairs 
obtained from Dr P. DCmant, Institute of Experimental Biology and Genetics, Praha, 
Czechoslovakia, and from Dr D. Shreffler, Department of Human Genetics, University 
of Michigan Medical School, AM Arbor, Michigan, U.S.A. B1O.M were obtained from 
Searle Research Laboratories, High Wycombe, England. 
Antisera 
The different allogeneic and xenogeneic sera were obtained as described by Halloran et ai. 
(1975) and Arnaiz-Villena & Hay, (1975). IgG and F(ab)z fragments were obtained as 
detailed by Halloran et al. (1974). 
Table 1 shows details about H-2 antisera. Sera 3, 4, 6, and 7 were obtained from the 
Transplantation Immunology Branch, N.I.A.I.D., N.I.H., Bethesda, Md., U.S.A., (Snell, 
1968). 
Preparation of EAC 
Sheep red blood cells (SRBC, E), rabbit anti-SRBC antibody (A) at subagglutinating 
doses or alternatively pure mouse IgM anti-SRBC (from Dr F. C. Hay) and fresh mouse 
complement were used as described by Arnaiz-Villena et al. (1974). Complement was ob- 
tained by axillary bleeding of (BlO.BR x BIO)F1* hybrids, blood being kept at 4°C to 
separate the serum, which was always used the same day. A h a 1  suspension of EAC was 
made up in veronal buffered physiological saline, containing CaZ+ and MgZ+ (VBS). 
* The source of complement appears to have no bearing on the results. @ALB/c x C57B1/6)FI and 
BALB/c have also been used, with identical results. 
CRIS: A new H-2 linked polymorphism 
TABLE 1.  Specificity of H-2 antisera 
(I)  BALB/c anti CBA 
(2) A.TH anti A.TL 
(3) (B10 x LP.RIII)F, anti BlO.A(2R) 
(dddddd kkkkkk) * 
skkkkd) (sss ssd  
bbbbbb kkkddb) -
(4) (B10 x LP.RIII)FI anti BlO.A(5R) 
-
(- 
bbbbbb (- bbbddd) -
(5) (B10 anti BlO.A(5R) 
(6) (C3H.SW x HTG)F, anti C3H-OH 
bbbddd) -(bbbbbb 
bbbbbb kmiJ dddddi) 
(7) (B1O.AK.M x 129)FI anti BIO.A 
kkkkkq (= kkkddd) -
(8) (A.BY xHTT)F1 anti A.TL 
bbbbbb skkkkd) - 
(9) (B10xA) anti B10. D2 
bbbbbb kimi - dddddd) 
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* The small case letters in brackets 
represent the alleles at the various 
regions and subregions of the H-2 
complex, designated by their genetic 
origin (e.g. b = H-Zb) and appearing 
in the following order: K, I-A, I-B, I-C, 
S, D. (Kleinet al., 1974). 
Cell suspensions 
Cell suspensions from spleen were obtained by teasing in VBS. Aggregates were allowed 
to sediment and the supernatant was collected. The cells were washed twice with VBS at 4°C 
and finally resuspended in VBS up to the adequate concentration. 
Inhibition and C'rosette assay 
The mouse cells, 5 x lo6, were incubated with 100 pl of the appropriate dilution of anti- 
serum in VBS for 20 min at room temperature. After two washes with cold VBS, cells were 
mixed together with EAC in VBS (50 EAC: 1 lymphocyte) in flat bottomed plastic tubes 
with caps (45 x 10 mm) and then left standing at room temperature for 1 hr. E and EA 
negative controls were run in parallel. 
Specific percentage inhibition was calculated by comparison with the amount of inhibi- 
tion of control cells by normal A.SW serum in each experiment, usually negligible. Total 
leucocytes and total rosettes were counted in the same field after adding one drop 0.01 % 
acridine orange into each tube and examining the cells under fluorescence microscopy, 
using simultaneous ultraviolet and visible transmitted light. At least 400 cells were counted. 
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RESULTS 
As presented in our earlier communication, (Arnaiz-Villena et al., 1975) the inhibitory 
activity was initially detected in two alloantisera involving H-2 or partial H-2 differences : 
A.TH anti-A.TL, and BALB/c anti-CBA/H. Preincubation of AKR spleen or lymph node 
cells with either of these antisera was found to inhibit their ability to form EAC rosettes. 
. BALB/c cells were unaffected by these antisera. The inhibition was invariably found to be 
only partial (70% with spleen cells, 8690% with lymph node cells), and little or no in- 
hibition occurred with bone marrow cells. Since the use of EDTA allows one to study either 
'myeloid' (EDTA sensitive) or 'lymphoid' (EDTA resistant) rosette forming cells (Lay & 
Nussenzweig, 1968; Amaiz-Villena et al., 1974) we were able to show that only the 'lym- 
phoid' population of EAC rosette forming cells in spleen and lymph node were inhibited 
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FIG. 1. Inhibition of complement receptors by A.TH anti-A.TL serum in AKR spleen cells. 
In the present studies, we sought to determine whether the inhibitory activity was anti- 
body. The observation that normal mouse sera showed no inhibitiory activity and that the 
activity appeared after immunization was suggestive. Also, Fig. 1 shows results with IgG 
and F(ab')2 fractions of the A.TH anti-A.TL serum. The strong inhibition of EAC rosettes 
observed with the F(ab'), preparation is most compatible with an antibody acting by 
binding to the cell surface by the antibody combining site, independent of the Fc portion of 
the molecule. Further evidence that the activity was antibody was the demonstration that 
the activity could be specifically absorbed, as described later. 
What was the linkage of the genetic control of CRIS? Some preliminary studies done in 
highly inbred F2 recombinant mice (provided by B. Taylor) have strongly suggested that at 
least some of the genetic control segregates together with the H-2 type of the mouse in the 
DBA/2 x C57B1/6 combination tested; further studies to confirm these findings are in 
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progress. In addition, some studies in congenic mouse strains have been done, as shown in 
table 2. Since B10 was negative (i.e. not inhibited) and BIO.A was positive (i.e. inhibited), a 
locus in the IXth linkage group was indicated. Since BIO.A(SR) was positive, this locus 
must be to the right of I-B, and since BlO.A(2R) was positive it must be to the left of H-2D. 
Thus an H-2 locus between the I-B subregion and the D region (either I-C or S )  must make 
some contribution to the genetic control of CRIS. 
TABLE 2. C receptor blocking by A.TH a A.TL serum in B10 congeneic series 
H-2 region 
Normal CRC % C' rosette 
Strain K I-A I-B I-C S D numbers * inhibition? 
B10 b b b b b b  31 4 5  0 
BIO.A k k k d d d  30 t 6 72 + 5 
BlO.A&R) k k k d d / b  2 3 + 4  70 L- 3 
BlO.A(4R) k k / b  b b b 22 k 5 0 
BlO.A(SR) b b b / d  d d 3 3 k 6  71 + 5  
BlO.A(R233)t k k k d d / b  2 6 + 2  74 * 5 
* Values are mean f of 5 separate experiments. CRC = complement receptor cells. 
t See footnote to Table 3. 
1 So far H-2 undistinguishable from BlO.A(2R) P. Dkmant (personal communication) 
The strain distribution of the characteristic CRIS as defined by the two antisera (A.TH a 
A.TL and BALB/c u CBA/H) is shown in Table 3. Since AKR and BIO.A had previously 
been shown to be positive for CRIS, it was not surprising that the positive strains should 
have I-Ck/Sk or I-Cd/Sd in their H-2 haplotypes. Yet some of the negative strains were 
apparently H-2 identical with positive strains : BALB/c (H-2d) was negative but DBA/2 
(H-2d) was positive; BlO.BR, CBA/H, and C3H (all H-2k) were negative but AKR (H-2k) 
was positive. Also the antiserum BALB/c anti CBA/H was negative with CBA/H, which 
was the immunizing strain, and positive with AKR. These data implied that the H-2 linked 
genetic control dzmonstrated in the congenic mice could not alone explain the strain 
distribution of the characteristic CRIS. Another observation shown in Table 3 is that CRIS 
is expressed in a dominant fashion in the (BALB/c x AKR)F1 mice. 
Further clarification of the question of genetic control was sought through absorption 
experiments. Table 4 shows that while CBA/H cells are not themselves inhibited by the 
antisera BALB/c anti-CBA/H or A.TH anti-A.TL, they will absorb much of the inhibitory 
activity (as tested on AKR cells) out of these antisera. BALB/c cells were not inhibited by 
the antisera, nor would they absorb out the inhibitory activity. AKR cells were inhibited by 
the antisera and would also absorb out the activity. Thus at least three phenotypes are 
possible for the characteristic CRIS: inhibition +, absorption + (e.g. AKR); inhibition -, 
absorption + (e.g. CBA/H); inhibition -, absorption - (e.g. BALB/c). This situation 
strongly suggests the operation of a non H-2 genetic locus in the control of CRIS, in 
addition to the H-2 linked locus previously suggested. Genetic studies to confirm this 
conclusion are in progress. 
In order to obtain information about the genetic requirements for the production of the 
inhibitory antisera, we undertook to assess a variety of other antisera, directed against 
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TABLE 3. Strain distribution of C receptor inhibition by A.TH anti-A.TL and BALB/c anti-CBA antisera * 
~ ~ 
H-2 complex Normal CRC % inhibition % inhibition 
Strains (K I-A I-B I-C S D) number 11 A.TH aA.TLt  BALB/c a CBA 
Positive $ 
AKR k k k k k k  3 1 f 5  70 f 3 72 f 5 
DBA/2 d d d d d d  25 f 2 65 f 2 68 f 4 
A.JAX k k k d d d  29 f 6 63 + 2 67+ 1 
BIO.A k k k d d d  3 0 + 6  72 f 5 72 k 7 
B1O.HTT s s s k k d  31 f 1 7 5 f 4  70k 1 
A.TL s k k k k d  23 71 65 
2 7 & 4  68 f 1 69 k 5 
d d d d d d  
(BALB/c x AKR)FI 
Negative 
CBA/H k k k k k k  32 f 3 0 0 
C3H k k k k k k  3 0 f 4  0 0 
B1O.BR k k k k k k  28+4 0 0 
BALB/c d d d d d d  28 k 4 0 0 
C57B1/10 b b b b b b  31 f 5  0 0 
C57B1/6 b b b b b b  3 2 5 4  -2 -4 
B1O.M f f f f f f  2 8 f 6  3 0 
A.SW s s s s s s  2 7 k 4  3 0 
A.TH s s s s s s  20 0 0 4 
* Spleen cells were used throughout. 
f % inhibition = 100 x 1 -{[( % rosettes after test serum)/( % rosettes after A.SW serum)]}. Both sera 
$ Male and female mice were tested: results represent mean values from at least 3 different experiments. 
8 Only one experiment was done. 
11 Normal CRC numbers are the percentage of rosettes after preincubation with normal ASW serum 
were used at 1/100 dilution (plateau values). 
(which did not affect the normal numbers in each case). 
TABLE 4. Absorption of C' receptor inhibiting activity tested in AKR spleen cells 
Strain used for % C' rosette inhibition % C' rosette inhibition 
Serum absorption * after absorption t before absorption 3 
CBA/H (-) 







26 I . .~ 
AICR (+) 






+, strain susceptible to inhibition . 
-, strain non susceptible to inhibition 1 * In brackets = 
t Absorptions were accomplished by using 1 :5  (v :v) packed spleen cells: l /5 dilution of serum. After 
$ See footnote table 3. 
incubating 30 min at  37"C, the mixture. was placed rotating at 4°C for a further 6 hr. 






Strains and H-2 complex (K I-A I-B I-C S D) 
' I-vs kkkkkk 9 + 1  75 8 + 3  72 
2-vs skkkkd 1 0 f 3  12 9 + 1  69 
3-vs kkkddb 8 + 2  77 5 + 2  82 
"vs bbbddd 1 0 2 2  72 6 2 2  79 
5-vs bbbddd 5 + 3  86 6 + 3  79 
7-vs kkkddd 11 f 3  69 8 2 2  72 
8-vs s k k k G  3 0 + 6  16 27 f 4 6 









% CRC inhibition 
30+ 6 - 
7 + 3  76 
9 + 2  70 
8 rt: 1.5 73 
1 0 2 3  66 
7 f 2  76 
8 f 1  73 
8 2 1  73 
2 5 + 4  16 
30 0 
28 f 5 6 
29 f 2 3 
____ 
* For sera details consult table 1. 
t Values calculated from 3 separate experiments; % inhibition = 100 x 1 - [( % CRC (mean) test)/(% CRC 
(mean)control)] 1,2 :1/100dilution; Rest :7/20dilution. 
Numbers shown are mean of two separate experiments. 
BAB = brain associated theta. 
various H-2 regions, concentrating mainly on those antisera raised in congenic strains. 
Table 5 shows the results of these experiments. The significant facts about the antisera were: 
(i) mere binding of antibody to the cell surface was not sufficient to inhibit CR binding. 
Although rabbit anti-mouse Ig and rabbit anti mouse brain-associated O (BAO) bind to 
subpopulations of CR lymphoid cells (Arnaiz-Villena et al., 1974) no EAC rosette inhibition 
is seen with these antisera; (ii) an H-2 difference was sufficient to produce a positive serum; 
(iii) H-2 difference in the K, I-A or I-B region did not produce positive antisera (serum 8 and 
9); I-C, S or D region differences were required to produce positive sera, and all positive 
sera could be explained on the basis of a locus between the S and D regions, assuming that 
the crossing over between S and D occurs in different places in different recombinant 
strains. Other possibilities will be discussed later. 
To summarize, the findings point to the characteristic CRIS being under complex genetic 
controI, with at least part of the control being in the D end of the H-2 complex. The in- 
hibitory activity in antisera behaves like an antibody directed against antigens controlled by 
the D end of the H-2 complex. 
DISCUSSION 
We have established that a variety of anti-H-2 sera contain an activity capable of specifically 
inhibiting the EAC rosettes of certain mouse strains. The activity resembles an antibody in 
being present only in immune sera, being specific and absorbable, and being found in both 
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the IgG and F(ab'), fractions of the antisera. The activity seems to be raised against gene 
products controlled by the I-C, S or D regions of the H-2 complex, and the ability to be 
inhibited by the antisera seems to map in the I-C or S region, but is influenced by factors 
other than the mere presence of the gene product on the cell surface. From previous studies 
we know that only a subpopulation of CR bearing cells is inhibited in this way, perhaps 
because only this subpopulation expresses the gene product required to bind the antibody. 
Evidence indicates that this subpopulation is the lymphoid, rather than myeloid, sub- 
population of CR bearing cells. Therefore, EDTA sensitivity [MgZ+ dependence (Lay & 
Nussenzweig, 1968)] together with resistance to inhibition by H-2 antisera would be two 
characteristics of mouse myeloid CRs differentiating them from lymphoid CRs. 
The S region of the H-2 complex is a natural focus for attention for studies of complement 
receptor genetics. It has remained silent in terms of serologically detectable cell surface 
antigens, but it has been demonstrated that the S region controls serum complement 
levels in mouse (D6mant et al., 1973). Since it would be natural to expect that some cell 
surface antigens will be controlled by the S region (like the K, I, D, and TL regions) it 
would not be surprising if the S region controlled at least some aspects of the genetic control 
of CRs. However, the extreme complexity of complement systems, with their enzyme 
cascades and multiple inhibitors, leads us to suspect that complement receptors will depend 
on and be affected by serum proteins, cofactors and inhibitors in a similarly complicated 
fashion. Certainly the existence of several kinds of complement receptor has been reported 
in humans: for C3 and C3b (Theofilopoulos et al., 1974), for C4 (Bokisch & Sobel, 1974) 
and for C3d (Ross et al., 1973) and in mouse (Okada & Okada, 1974). 
One of the most puzzling findings in these experiments is that with the initial two antisera 
used to define CRIS, (A.TH a A.TL and BALB/c a CBA/H), BALB/c is negative but DBA/2 
is positive, and CBA/H is negative while AKR is positive., The possible explanations of 
these findings are worthy of consideration: (i) the antigen recognized by the inhibiting 
antibody is non H-2 linked; but how can this account for antibody production in congenic 
mice differing only in small segments of the H-2 complex? Also, this would not agree with 
the H-2 linkage shown for CRIS; (ii) H-2 haplotypes, such as H-2d may differ at previously 
unknown S or D region loci from one another, i.e. the H-2 complex of BALB/c and the 
H-2 complex of DBA/2 may be genotypically different. This explanation is unconventional 
but has been invoked previously to explain genetic findings in this region (Gelfand et al., 
1974); (iii) H-2 genes of genotypically H-2 identical mice (e.g. BALB/c and DBA/2) may 
produce gene products which are altered by non H-2 factors (? inhibitors, cofactors) to be 
phenotypically different, such that an S region antigen expressed in DBA/2 may be absent 
in BALB/c; (one preliminary observation compatible with this hypothesis is that antiserum 
BALB/c anti DBA/2 inhibits DBA/2 and AKR CR but not BALB/c CR, Arnaiz-Villena 6c 
Halloran, unpublished observations). 
Can the H-2 genetic influence on CRIS be correlated with any known H-2 linked gene? 
(for review see Shreffler & David, 1975). Certainly the T and Tla genes can be easily ruled 
out, as can the H-2K and H-2D genes as detected in conventional serological studies, 
because antisera raised between animals differing only in the I and S regions are positive. 
The Ia specificities currently known can be ruled out by the occurrence of positive sera 
raised across no I region differences (Table 5, serum 6). The H-2G region (David et a1.,1975; 
Klein et al., 1975) is incompletely understood but has no known gene products on cells 
other than erythrocytes, and the known alloantigen in this region could not explain these 
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findings. The S region has two known makers, the S protein and the sex-limited Slp trait, 
neither of which correlate with our findings. One interesting marker, CRL-1 (Gelfand et al., 
1974) in the D end of the H-2 complex to the right of S ,  has some interesting similarities with 
our CRIS H-2 linked component, but is distinguishable from it by its mapping and strain 
distribution (for example, BlO.A(2R) is positive for CRIS but negative for CRL-1). At present 
we can find no H-2 linked characteristic which correlates with the H-2 linked CRIS locus. An 
obvious caveat in the interpretation of our findings is the relative lack of information about 
mouse C' and CRs, the factors regulating them, and their interactions with one another. 
For example, could complement components and related enzymes, which are found and 
possibly produced in lymphoid tissues, alter the behaviour of the CR so that CRIS positive 
cells could become CRIS negative? If so, this would help to explain how mice which are 
apparently genotypically identical at the H-2 locus could be phenotypically different for an 
H-2 linked characteristic. Furthermore, what is the role of the antibody in CR inhibition, 
and is there any role for complement components in the antiserum in the inhibition, since 
complement components have been shown to modify CR binding (Miller et al., 1973)? Any 
such interactions would have to take into account that the F(ab'), portions of the antibody 
are almost as inhibitory as the IgG, and the high titre of the activity in some sera. 
For now, a working hypothesis for the ability of anti-H-2 sera to inhibit CR would involve 
interaction of the antibody with the product of an H-2 linked gene (possibly located between 
Ss and H-2D) which would result in inhibition or non inhibition depending upon influence 
from other genes, possibly non H-2 linked. 
We are particularly interested in the implications of this work for H-2 serology (and the 
serologic study of the major histocompatibility systems of other species). H-2 antisera 
contain new and previously unsuspected activities against D end antigens, undetected by 
conventional means. Furthermore, D end gene products seem to be intimately involved 
with the complement receptor, just as they are intimately involved in determining comple- 
ment receptor cell levels in neonatal spleens (Gelfand et al., 1974) and in serum complement 
levels (Demant et al., 1973). 
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